Search Results - "CURIEL, David T"

Refine Results
  1. 1

    Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic by Mendonça, Samir Andrade, Lorincz, Reka, Boucher, Paul, Curiel, David T.

    Published in npj vaccines (05-08-2021)
    “…Adenoviral vectors have been explored as vaccine agents for a range of infectious diseases, and their ability to induce a potent and balanced immune response…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 by Stephens, Calvin J., Lauron, Elvin J., Kashentseva, Elena, Lu, Zhi Hong, Yokoyama, Wayne M., Curiel, David T.

    Published in Journal of controlled release (28-03-2019)
    “…Hemophilia B (HB) is a life-threatening inherited disease caused by mutations in the FIX gene, leading to reduced protein function and abnormal blood clotting…”
    Get full text
    Journal Article
  4. 4

    Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9 by Stephens, Calvin J., Kashentseva, Elena, Everett, William, Kaliberova, Lyudmila, Curiel, David T.

    Published in Gene therapy (01-04-2018)
    “…Serum deficiency diseases such as alpha-1-antitrypsin deficiency are characterized by reduced function of serum proteins, caused by deleterious genetic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Radiation-induced cell signaling: inside-out and outside-in by Valerie, Kristoffer, Yacoub, Adly, Hagan, Michael P, Curiel, David T, Fisher, Paul B, Grant, Steven, Dent, Paul

    Published in Molecular cancer therapeutics (01-03-2007)
    “…Exposure of tumor cells to clinically relevant doses of ionizing radiation causes DNA damage as well as mitochondria-dependent generation of reactive oxygen…”
    Get full text
    Journal Article
  9. 9

    The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs by Ghisays, Fiorella, Brace, Cynthia S., Yackly, Shawn M., Kwon, Hyock Joo, Mills, Kathryn F., Kashentseva, Elena, Dmitriev, Igor P., Curiel, David T., Imai, Shin-ichiro, Ellenberger, Tom

    Published in Cell reports (Cambridge) (17-03-2015)
    “…The NAD+-dependent protein deacetylase SIRT1 regulates energy metabolism, responses to stress, and aging by deacetylating many different proteins, including…”
    Get full text
    Journal Article
  10. 10

    A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy by Hassan, Ahmed O., Dmitriev, Igor P., Kashentseva, Elena A., Zhao, Haiyan, Brough, Douglas E., Fremont, Daved H., Curiel, David T., Diamond, Michael S.

    Published in Cell reports (Cambridge) (03-09-2019)
    “…The teratogenic potential of Zika virus (ZIKV) has made the development of an effective vaccine a global health priority. Here, we generate two gorilla…”
    Get full text
    Journal Article
  11. 11

    Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation by Geng, Kexin, Rice-Boucher, Paul J, Kashentseva, Elena A, Dmitriev, Igor P, Lu, Zhi Hong, Goedegebuure, S Peter, Gillanders, William E, Curiel, David T

    Published in Viruses (01-11-2023)
    “…mRNA vaccines have attracted widespread research attention with clear advantages in terms of molecular flexibility, rapid development, and potential for…”
    Get full text
    Journal Article
  12. 12

    In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector by Lorincz, Reka, Alvarez, Aluet Borrego, Walkey, Christopher J., Mendonça, Samir A., Lu, Zhi Hong, Martinez, Alexa E., Ljungberg, Cecilia, Heaney, Jason D., Lagor, William R., Curiel, David T.

    Published in Biomedicine & pharmacotherapy (01-02-2023)
    “…Biological applications deriving from the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 site-specific nuclease system continue to…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses by Komarova, Svetlana, Kawakami, Yosuke, Stoff-Khalili, Mariam A, Curiel, David T, Pereboeva, Larisa

    Published in Molecular cancer therapeutics (01-03-2006)
    “…Natural and genetically modified oncolytic viruses have been systematically tested as anticancer therapeutics. Among this group, conditionally replicative…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypes by Uchino, Junji, Curiel, David T, Ugai, Hideyo

    Published in PloS one (04-02-2014)
    “…Species C human adenovirus serotype 5 (HAdV-C5) is widely used as a vector for cancer gene therapy, because it efficiently transduces target cells. A variety…”
    Get full text
    Journal Article
  18. 18

    A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology by Lee, Myungeun, Rice-Boucher, Paul J, Collins, Logan Thrasher, Wagner, Ernst, Aulisa, Lorenzo, Hughes, Jeffrey, Curiel, David T

    Published in Viruses (30-09-2022)
    “…Molecular therapies exploiting mRNA vectors embody enormous potential, as evidenced by the utility of this technology for the context of the COVID-19 pandemic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein by Mukherjee, Jean, Dmitriev, Igor, Debatis, Michelle, Tremblay, Jacqueline M, Beamer, Gillian, Kashentseva, Elena A, Curiel, David T, Shoemaker, Charles B

    Published in PloS one (29-08-2014)
    “…Current therapies for most acute toxin exposures are limited to administration of polyclonal antitoxin serum. We have shown that VHH-based neutralizing agents…”
    Get full text
    Journal Article